High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy.
Hepatitis C virus (HCV) is a highly mutable RNA virus and circulates as a heterogeneous population in individual patients. The magnitude of such population heterogeneity has long been proposed to be linked with diverse clinical phenotypes, including antiviral therapy. Yet data accumulated thus far a...
Main Authors: | Weihua Wang, Xiaoan Zhang, Yanjuan Xu, George M Weinstock, Adrian M Di Bisceglie, Xiaofeng Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4065037?pdf=render |
Similar Items
-
Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
by: Curtis L Cooper, et al.
Published: (2008-01-01) -
Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin
by: Delić Dragan, et al.
Published: (2005-01-01) -
Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
by: Ching-Chung Lin, et al.
Published: (2014-07-01) -
Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C
by: Zehui Yan, et al.
Published: (2012-01-01) -
Psychosis during peginterferon-alpha2a and ribavirin therapy: case report
by: Lucas C. Quarantini, et al.